Hyperlipoproteinemia type V
MONDO:0007762A severe type of hyperlipidemia, sometimes familial, that is characterized by the elevation of both plasma chylomicrons and triglycerides contained in very-low-density lipoproteins. Type V hyperlipoproteinemia is often associated with diabetes mellitus and is not caused by reduced lipoprotein lipase activity as in hyperlipoproteinemia type I.
Also known as: HLP type 5, familial APOA5 deficiency, familial apolipoprotein A-V deficiency, familial apolipoprotein A5 deficiency, major hyperlipidemia, hyperchylomicronemia late onset, hyperchylomicronemia with Hyperprebetalipoproteinemia, familial, hyperchylomicronemia, late-onset
3 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
New study aims to boost statin use with simple doctor nudges
Disease control OngoingThis study tests two methods to increase referrals to a centralized pharmacy service for managing statin therapy in patients with or at high risk for heart disease. One method sends reminders to doctors during office visits, and the other sends electronic messages outside of visi…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Computer alert aims to boost cholesterol treatment in heart patients
Disease control OngoingThis study tests whether an electronic alert in the medical record can help doctors prescribe better cholesterol-lowering medications for heart disease patients with high LDL. About 400 patients from a single hospital will be randomly assigned to have their doctor receive the ale…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC